HERA-CD137 Trademark
HERA-CD137 is a USPTO trademark filed by Apogenix AG. Status: Registered.
Trademark Facts
| Mark | HERA-CD137 |
|---|---|
| Serial Number | 79262797 |
| Registration Number | 6071817 |
| Status | Registered |
| Filing Date | 2019-05-08 |
| Registration Date | 2020-06-09 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT) |
| Owner | Apogenix AG |
| Attorney of Record | Andrew J. Ferren |
| Prosecution Events | 25 |
| Latest Event | REM3 on 2025-06-09 |
Goods & Services
Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety